Clinical Trial Update: The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating conversion surgery for apatinib plus SOX in patients with unresectable gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)
• SOX (SOX)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN